NCT06422871View on ClinicalTrials.gov

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 28, 2025

Primary Completion Date

June 28, 2027

Study Completion Date

December 28, 2028

Conditions
End Stage Renal DiseaseHemodialysis Access Failure
Interventions
DEVICE

HeRO® Graft System or Super HeRO® System

Treatment attempted with the HeRO® or Super HeRO® device.

Trial Locations (3)

27610

RECRUITING

WakeMed, Raleigh

34239

RECRUITING

Sarasota Memorial Health Care System, Sarasota

75226

RECRUITING

Baylor Scott & White Heart and Vascular Hospital - Dallas, Dallas

Sponsors
All Listed Sponsors
lead

Merit Medical Systems, Inc.

INDUSTRY

NCT06422871 - PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis | Biotech Hunter | Biotech Hunter